logo
logo
Registered Office. 7 The Close, Norwich NR1 4DJ. Company Number. 07974296. Registered in England and Wales

bio image

Dr Mark Sanders has worked as a Consultant in Anaesthesia and Pain Medicine since 2002 and has a particular interest in the management of acute and chronic pain.

 

Dr Sanders attained his MB BS from the University of London in 1992 and the Fellowship of the Royal College of Anaesthetists (FRCA) in 1996. His anaesthetic and pain training was based in the Wessex School of Anaesthesia, working in Salisbury, Southampton and Poole/Bournemouth hospitals.

He then sought further experience through an appointment as an Associate Professor in Anaesthesia and Pain Medicine at the internationally renowned University of Washington, Seattle.

In 2002, Dr Sanders was appointed as a Consultant in Anaesthesia and Pain medicine at the Norfolk & Norwich University Hospital (NNUH). He has sessional commitments to anaesthesia, acute pain management and chronic pain medicine. Each year he undertakes the assessment of approximately 1,500 patients and performs in excess of 500 pain procedures.

He was awarded the Fellowship of the Faculty of Pain Medicine of the Royal College of Anaesthetists (FFPMRCA) in 2007 and was appointed Clinical Director for Anaesthesia, Pain Medicine and Critical Care in July 2010 and an Associate Medical Director in 2015. His GMC registration number is 3658815.

Expert witness experience

Dr Sanders also has experience in reviewing conduct and capability according to the principles of MHPS and has presented evidence to the General Medical Council. His practice is maintained by regular attendance at courses organised by Bond Solon and Professional Solutions.

Research and publications

Dr Sanders has an active research program, principally into chronic opiate usage and Complex Regional Pain Syndrome. His publications include:

  • Jatinder Bisla, Gareth Ambler et al: Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above target. December 2019, British Journal of Pain, DOI: 10.1177/2049463719893399
  • Katherine Deane, Richard Gray et al: Patient-directed self-management of pain (PaDSMaP) compared to treatment as usual following total knee replacement; a randomised controlled trial. May 2018, BMC Health Services Research 18(1):346, DOI: 10.1186/s12913-018-3146-2
  • Andreas Goebel, Mark Sanders et al: Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome, A Randomized Trial. October 2017, Annals of internal medicine 167(7)
  • Mark Sanders, Stephen Jones, Oliver Löwenstein, Jan-Peter Jansen, Hubert Miles, Karen Simpson: New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects. Pain Medicine 06/2015; 16(8). DOI:10.1111/pme.12775
  • Andreas Goebel, Nicholas Shenker, Nick Padfield, Karim Shoukrey, Candida McCabe, Mick Serpell, Mark Sanders, Caroline Murphy, Amaka Ejibe, Holly Milligan, Joanna Kelly, Gareth Ambler: Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): Study protocol for a randomized controlled trial. Trials 10/2014; 15(1):404. DOI:10.1186/1745-6215-15-404
  • Mark Rochester, James Armitage, Mark Sanders, Paula Christmas: Self Management Activation Randomised Trial for Prostatitis (SMART-P): Study protocol for a randomised controlled trial. Trials 09/2011; 12:210. DOI:10.1186/1745-6215-12-210
  • M K Sanders, M Y K Wee: Multicompartment block in a parturient undergoing urgent Caesarean section. European Journal of Anaesthesiology 04/2002; 19(3):226-8. DOI:10.1017/S0265021502230380

 

Contact